STOCK MARKET BSE NSE

WHO chief thanks Health Minister Mansukh Mandaviya for announcing resumption of COVID vaccine export

Mandaviya on Monday announced that India will resume export of surplus COVID-19 vaccines in the fourth quarter of 2021 under the 'Vaccine Maitri' programme.

Published: 22nd September 2021 10:32 AM  |   Last Updated: 22nd September 2021 10:33 AM   |  A+A-

Union Health Minister Mansukh Mandaviya

Union Health Minister Mansukh Mandaviya (Photo | PTI)

By PTI

NEW DELHI: World Health Organisation (WHO) chief Tedros Adhanom Ghebreyesus on Wednesday thanked Union Health Minister Mansukh Mandaviya for announcing resumption of COVID-19 vaccine shipments to the COVAX global pool in October.

COVAX is an initiative for equitable global access to COVID-19 vaccines. "Thank you Health Minister @mansukhmandviya for announcing #India will resume crucial #COVID19 vaccine shipments to #COVAX in October. This is an important development in support of reaching the 40% vaccination target in all countries by the end of the year. #VaccinEquity," Ghebreyesus said in a tweet.

Mandaviya on Monday announced that India will resume export of surplus COVID-19 vaccines in the fourth quarter of 2021 under the 'Vaccine Maitri' programme and to meet its commitment to the COVAX global pool, but vaccinating its own citizens remains the topmost priority of the government.

Talking about the expected production and supply trends in the coming months, the minister said the government will receive over 30 crore doses of COVID-19 vaccines in October and over 100 crore doses in the coming quarter from October-December.

The cumulative doses administered so far across the country has crossed 82.65 crore.

Asserting that vaccination of its citizens remains the government's topmost priority, Mandaviya had said, "India will be resuming export of COVID-19 vaccines under Vaccine Maitri in order to fulfil the commitment of India towards COVAX in line with our motto of 'Vasudhaiva Kutumbakam'."

He said that the surplus supply of vaccines will be used to fulfil India's commitment towards the world for the collective fight against COVID-19. COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and the WHO.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp